Effect of Sacubitril/Valsartan on Reducing the Risk of Arrhythmia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

BACKGROUND AND OBJECTIVE: Relevant data of PARADIGM-HF reveals sacubitril/valsartan (SV) therapy led to a greater reduction in the risks of arrhythmia, and sudden cardiac death than angiotensin converting enzyme inhibitor (ACEI)/angiotensin receptor inhibitor (ARB) therapy in HFrEF, however, inconsi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ruxin, Ye, Haowen, Ma, Li, Wei, Jinjing, Wang, Ying, Zhang, Xiaofang, Wang, Lihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289747/
https://www.ncbi.nlm.nih.gov/pubmed/35859597
http://dx.doi.org/10.3389/fcvm.2022.890481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289747/
https://www.ncbi.nlm.nih.gov/pubmed/35859597
http://dx.doi.org/10.3389/fcvm.2022.890481

Ejemplares similares